Skip to content

Human papillomavirus and oropharyngeal cancer trends

Published: October 18, 2026Updated: October 18, 2026

Gillison ML, D'Souza G, Larson W

JAMA · 2019

This cohort study evaluates the intervention under study in relation to the primary clinical outcome. Includes 13,964 participants. Evidence level: IIb.

Quick summary

Evidence-Based Research: P16 Ink4a Oropharyngeal Cancer

Medically reviewed by WellAlly Editorial TeamLast reviewed October 18, 2026Editorial policy

Key facts at a glance

DOI
10.1001/jama.2019.6978
PMID
31338369
Journal
JAMA
Year
2019
Study type
cohort
Evidence level
IIb
Sample size
13964
Intervention
HPV 感染状态
Primary outcome
口咽癌发生率
Open access
false

Study Overview

This cohort study enrolled 13,964 participants and examined the primary clinical outcome.

Key Findings

Results regarding the primary clinical outcome are presented.

Clinical Conclusions

See original publication for detailed findings. Evidence level: IIb.

Abstract

"This cohort study enrolled 13,964 participants, investigating the effects of HPV 感染状态 on 口咽癌发生率.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy

More cohort studies

View all